Inhibition of histone deacetylases accelerates wound healing in diabetic skin and is associated with vascularization and epidermal tight junction protein expression.
Juan Valentin Trujillo-Paez, Adrián Rodríguez-Carlos, Nancy Solís-Torres, Yessica E Félix-García, Irma González-Curiel, Luis Adrián De Jesús-González, Crisol Rodriguez Mendieta, César Rivas-Santiago, Bruno Rivas-Santiago
{"title":"Inhibition of histone deacetylases accelerates wound healing in diabetic skin and is associated with vascularization and epidermal tight junction protein expression.","authors":"Juan Valentin Trujillo-Paez, Adrián Rodríguez-Carlos, Nancy Solís-Torres, Yessica E Félix-García, Irma González-Curiel, Luis Adrián De Jesús-González, Crisol Rodriguez Mendieta, César Rivas-Santiago, Bruno Rivas-Santiago","doi":"10.1016/j.tice.2026.103868","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic wounds in diabetic patients, represent a significant clinical challenge due to impaired epidermal barrier function and deficient wound healing. The development of novel therapeutic strategies aimed at enhancing both barrier integrity and wound healing is therefore critical. Recent evidence suggests that histone deacetylase inhibitors (iHDACs) may modulate wound healing.</p><p><strong>Objective: </strong>This study aimed to evaluate the effect of iHDACs, 1,3-Diphenylurea (DiPU), 2'-Aminoacetanilide (Ace), and Tert-butyl (2-aminophenyl) carbamate (N-boc), on epidermal barrier integrity and tight junction (TJ) protein expression, as well as their ability to promote wound healing and vascularization under diabetes conditions.</p><p><strong>Methods: </strong>Diabetes was induced in mice by streptozotocin (STZ) administration. Full-thickness excisional wounds were created, and wound closure was quantified by digital planimetry. Tissue samples were analyzed by H&E and Masson's trichrome staining to assess histological changes and collagen deposition. claudin-1, ZO-1, and occludin were evaluated by immunohistochemistry. Vascularization was quantified by measuring microvessel density.</p><p><strong>Results: </strong>Treatment with iHDACs improved re-epithelialization and increased the expression of tight junction proteins, suggesting restoration of molecular components associated with epidermal barrier integrity. Moreover, all treatments promoted wound closure. Macroscopic observations and quantitative analyses further demonstrated that N-boc and Ace significantly enhanced the formation of denser and more organized vascular networks in both healthy and diabetic mice, whereas DiPU produced a more moderate pro-angiogenic response in diabetic wounds.</p><p><strong>Conclusion: </strong>These findings indicate that iHDACs may offer therapeutic benefit by reinforcing epidermal barrier function and stimulating wound healing and vascularization, supporting their potential use as treatments for chronic wounds.</p>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"104 Pt 1","pages":"103868"},"PeriodicalIF":3.1000,"publicationDate":"2026-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tissue & cell","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.tice.2026.103868","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANATOMY & MORPHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Chronic wounds in diabetic patients, represent a significant clinical challenge due to impaired epidermal barrier function and deficient wound healing. The development of novel therapeutic strategies aimed at enhancing both barrier integrity and wound healing is therefore critical. Recent evidence suggests that histone deacetylase inhibitors (iHDACs) may modulate wound healing.
Objective: This study aimed to evaluate the effect of iHDACs, 1,3-Diphenylurea (DiPU), 2'-Aminoacetanilide (Ace), and Tert-butyl (2-aminophenyl) carbamate (N-boc), on epidermal barrier integrity and tight junction (TJ) protein expression, as well as their ability to promote wound healing and vascularization under diabetes conditions.
Methods: Diabetes was induced in mice by streptozotocin (STZ) administration. Full-thickness excisional wounds were created, and wound closure was quantified by digital planimetry. Tissue samples were analyzed by H&E and Masson's trichrome staining to assess histological changes and collagen deposition. claudin-1, ZO-1, and occludin were evaluated by immunohistochemistry. Vascularization was quantified by measuring microvessel density.
Results: Treatment with iHDACs improved re-epithelialization and increased the expression of tight junction proteins, suggesting restoration of molecular components associated with epidermal barrier integrity. Moreover, all treatments promoted wound closure. Macroscopic observations and quantitative analyses further demonstrated that N-boc and Ace significantly enhanced the formation of denser and more organized vascular networks in both healthy and diabetic mice, whereas DiPU produced a more moderate pro-angiogenic response in diabetic wounds.
Conclusion: These findings indicate that iHDACs may offer therapeutic benefit by reinforcing epidermal barrier function and stimulating wound healing and vascularization, supporting their potential use as treatments for chronic wounds.
期刊介绍:
Tissue and Cell is devoted to original research on the organization of cells, subcellular and extracellular components at all levels, including the grouping and interrelations of cells in tissues and organs. The journal encourages submission of ultrastructural studies that provide novel insights into structure, function and physiology of cells and tissues, in health and disease. Bioengineering and stem cells studies focused on the description of morphological and/or histological data are also welcomed.
Studies investigating the effect of compounds and/or substances on structure of cells and tissues are generally outside the scope of this journal. For consideration, studies should contain a clear rationale on the use of (a) given substance(s), have a compelling morphological and structural focus and present novel incremental findings from previous literature.